Novel 6-aminofuro[3,2-c]pyridines as potent, orally efficacious inhibitors of cMET and RON kinases
Arno G. Steinig, Mark J. Mulvihill(FuelCell Energy (United States)), Ti Wang(Wuhan University), Mridula Kadalbajoo, Kathryn M. Stolz, Andy Cooke, Jen Workman, Roy Turton, Christine Mantis(Northwestern University), Darla Landfair, Jonathan A. Pachter(Verastem (United States)), Prafulla C. Gokhale(Harvard University), Linda Crew, Peng Yue(Xinjiang Institute of Materia Medica), Andrew Kleinberg, Maryland Franklin, Jennifer Kahler, Mark R. Albertella(Mission Therapeutics (United Kingdom)), Xin Chen(Southwest University), Jing Wang(Sun Yat-sen University), Hanqing Dong, An‐Hu Li(FuelCell Energy (United States)), Meizhong Jin, Ryan Schulz, Mark Bittner, Julie L.C. Kan(Howard Hughes Medical Institute), David Epstein, Paula A. Tavares-Greco, Robert Wild, Caterina Ferraro
Cited by 15
Related Papers
K <sup>+</sup> Channel Mutations in Adrenal Aldosterone-Producing Adenomas and Hereditary Hypertension
|Science|2011|983
<i>Ex Vivo</i> Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids
|Cancer Discovery|2017|591
SNPs3D: Candidate gene and SNP selection for association studies
|BMC Bioinformatics|2006|463